Abstract
In 1992, the Committee on Infectious Diseases and Committee on Fetus and Newborn of the American Academy of Pediatrics provided guidelines for prevention of early-onset group B streptococcal (GBS) disease through intrapartum chemoprophylaxis of selected maternal GBS carriers.1 The guidelines were based on demonstrated efficacy in randomized, controlled clinical trials and selected only women with GBS colonization who had an obstetric risk factor.2 The guidelines were controversial34and their implementation incomplete.5 Since 1992, additional data have become available, and experience with the guidelines has been gained in numerous medical centers. Recently, consensus guidelines were developed by obstetricians, pediatricians, family practitioners, and public health authorities and published by the Centers for Disease Control and Prevention.6 These recommendations are supported by the American College of Obstetricians and Gynecologists7 and the American Academy of Pediatrics. This statement reviews the selection of pregnant women for chemoprophylaxis and provides an algorithm for management of their newborns.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference33 articles.
1. Guidelines for prevention of group B streptococcal infection by chemoprophylaxis.;American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn;Pediatrics,1992
2. Group B streptococcal infections: an obstetrical viewpoint.;Larsen;Pediatrics.,1993
3. Group B streptococcal infections in pregnancy: ACOG's recommendations.;American College of Obstetricians and Gynecologists;ACOG Newsletter.,1993
4. Barriers to prevention of perinatal group B streptococcal disease.;Jafari;Pediatr Infect Dis J.,1995
Cited by
283 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献